Skip to main content
. Author manuscript; available in PMC: 2011 Jan 22.
Published in final edited form as: Biochem Biophys Res Commun. 2009 Dec 31;391(4):1769–1774. doi: 10.1016/j.bbrc.2009.12.151

Figure 2. HRD genes with significant fold change (negative for down-regulation) of the expression level during maturation in NOR (A), CIH (B) and CCH (C).

Figure 2

Note that much larger numbers of genes changed the expression level during the development in hypoxia and the lack of overlap between the effects of CIH and CCH. Genes: Atp1a1 = ATPase, Na+/K+ transporting, alpha 1 polypeptide, Atp2a2 = ATPase, Ca++ transporting, cardiac muscle, slow twitch 2, Ctnna1 = Catenin (cadherin associated protein), alpha 1, Dsg2 = Desmoglein 2, Gaa = Glucosidase, alpha, acid, Hand2 = Heart and neural crest derivatives expressed transcript 2, Mef2a/b/c = Myocyte enhancer factor 2A/B/C, Pcdh12/7 = Protocadherin 12/7, Pkp4 = Plakophilin 4, Smyd1 = SET and MYND domain containing 1, Tbx5 = T-box 5.